Paolo Omodei

2.3k total citations
16 papers, 479 citations indexed

About

Paolo Omodei is a scholar working on Genetics, Infectious Diseases and Epidemiology. According to data from OpenAlex, Paolo Omodei has authored 16 papers receiving a total of 479 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 6 papers in Infectious Diseases and 6 papers in Epidemiology. Recurrent topics in Paolo Omodei's work include Inflammatory Bowel Disease (8 papers), COVID-19 Clinical Research Studies (5 papers) and Autoimmune and Inflammatory Disorders (3 papers). Paolo Omodei is often cited by papers focused on Inflammatory Bowel Disease (8 papers), COVID-19 Clinical Research Studies (5 papers) and Autoimmune and Inflammatory Disorders (3 papers). Paolo Omodei collaborates with scholars based in Italy, China and United States. Paolo Omodei's co-authors include Maurizio Vecchi, Roberto de Franchis, Alessio Aghemo, Silvio Danese, Maurizio Cecconi, Antonio Voza, Simone Saibeni, Alessandro Repici, Nicola Pugliese and Michele Ciccarelli and has published in prestigious journals such as Gastroenterology, Gut and Gastrointestinal Endoscopy.

In The Last Decade

Paolo Omodei

16 papers receiving 469 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paolo Omodei Italy 10 185 148 138 131 108 16 479
Edoardo Vespa Italy 11 148 0.8× 234 1.6× 40 0.3× 65 0.5× 65 0.6× 47 474
Luiz Estevam Ianhez Brazil 17 98 0.5× 221 1.5× 64 0.5× 171 1.3× 40 0.4× 54 729
Erica J. Brenner United States 12 639 3.5× 98 0.7× 260 1.9× 112 0.9× 290 2.7× 32 905
Soo-Kyung Park South Korea 10 49 0.3× 171 1.2× 277 2.0× 211 1.6× 66 0.6× 22 727
H. Gil France 11 65 0.4× 59 0.4× 27 0.2× 271 2.1× 103 1.0× 47 628
Klaus Herrlinger Germany 9 52 0.3× 184 1.2× 389 2.8× 283 2.2× 106 1.0× 26 585
Jérôme Olagne France 11 302 1.6× 113 0.8× 35 0.3× 72 0.5× 231 2.1× 33 853
Stéphanie Hamonic France 12 56 0.3× 157 1.1× 27 0.2× 58 0.4× 154 1.4× 24 540
Priya S. Verghese United States 15 129 0.7× 159 1.1× 26 0.2× 160 1.2× 323 3.0× 56 842
Anne Lohse France 15 275 1.5× 115 0.8× 27 0.2× 103 0.8× 36 0.3× 39 723

Countries citing papers authored by Paolo Omodei

Since Specialization
Citations

This map shows the geographic impact of Paolo Omodei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paolo Omodei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paolo Omodei more than expected).

Fields of papers citing papers by Paolo Omodei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paolo Omodei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paolo Omodei. The network helps show where Paolo Omodei may publish in the future.

Co-authorship network of co-authors of Paolo Omodei

This figure shows the co-authorship network connecting the top 25 collaborators of Paolo Omodei. A scholar is included among the top collaborators of Paolo Omodei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paolo Omodei. Paolo Omodei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Colapietro, Francesca, Giovanni Angelotti, Chiara Masetti, et al.. (2023). Ursodeoxycholic Acid Does Not Improve COVID-19 Outcome in Hospitalized Patients. Viruses. 15(8). 1738–1738. 12 indexed citations
2.
Danese, Silvio, Zhi Hua Ran, Alessandro Repici, et al.. (2020). Gastroenterology department operational reorganisation at the time of covid-19 outbreak: an Italian and Chinese experience. Gut. 69(6). 981–983. 28 indexed citations
3.
Aghemo, Alessio, Daniele Piovani, Tommaso Lorenzo Parigi, et al.. (2020). COVID-19 Digestive System Involvement and Clinical Outcomes in a Large Academic Hospital in Milan, Italy. Clinical Gastroenterology and Hepatology. 18(10). 2366–2368.e3. 40 indexed citations
4.
Anderloni, Andrea, Alessandro Fugazza, Luca Maroni, et al.. (2020). New biliary and pancreatic biodegradable stent placement: a single-center, prospective, pilot study (with video). Gastrointestinal Endoscopy. 92(2). 405–411. 38 indexed citations
5.
Cecconi, Maurizio, Daniele Piovani, Enrico Brunetta, et al.. (2020). Early Predictors of Clinical Deterioration in a Cohort of 239 Patients Hospitalized for Covid-19 Infection in Lombardy, Italy. Journal of Clinical Medicine. 9(5). 1548–1548. 126 indexed citations
6.
Masetti, Chiara, Elena Generali, Francesca Colapietro, et al.. (2020). High mortality in COVID‐19 patients with mild respiratory disease. European Journal of Clinical Investigation. 50(9). e13314–e13314. 31 indexed citations
7.
Anderloni, Andrea, Alessandro Fugazza, Luca Maroni, et al.. (2019). 1111 FEASIBILITY OF NEW BILIARY AND PANCREATIC BIODEGRADABLE STENT PLACEMENT: INTERIM ANALYSIS OF AN ONGOING SINGLE-CENTER, PROSPECTIVE, PILOT STUDY. Gastrointestinal Endoscopy. 89(6). AB136–AB136. 2 indexed citations
8.
Danese, Silvio, Gionata Fiorino, Stefania Vetrano, et al.. (2009). T1687 Infliximab Inhibits Mucosal Pathological Angiogenesis in Crohn's Disease. Gastroenterology. 136(5). A–558. 2 indexed citations
9.
Danese, Silvio, Erika Angelucci, Tommaso Stefanelli, et al.. (2008). Cytapheresis in Inflammatory Bowel Diseases: Current Evidence and Perspectives. Digestion. 77(2). 96–107. 6 indexed citations
10.
Correale, Carmen, Stefania Vetrano, Tommaso Stefanelli, et al.. (2008). W1213 Lymphoneogenesis: A New Component in Inflammatory Bowel Disease Pathogenesis. Gastroenterology. 134(4). A–656. 1 indexed citations
11.
Danese, Silvio, Nico Pagano, Erika Angelucci, et al.. (2007). Tumor Necrosis Factor-Alpha Monoclonal Antibodies for Crohns Disease: Tipping the Balance. Current Medicinal Chemistry. 14(14). 1489–1497. 5 indexed citations
12.
Repici, Alessandro, Paoletta Preatoni, Silvio Danese, et al.. (2007). A Prospective Study Comparison of Narrow Band Imaging (NBI) Versus Chromoendoscopy with Indigo Carmine (IC) Versus White Light (WL) Colonoscopy in the Detection of Adenomatous Colonic Lesions. Gastrointestinal Endoscopy. 65(5). AB351–AB351. 4 indexed citations
13.
Laghi, Luigi, Simone Saibeni, Paolo Bianchi, et al.. (2005). Carriage of CARD15 variants and smoking as risk factors for resective surgery in patients with Crohn's ileal disease. Alimentary Pharmacology & Therapeutics. 22(6). 557–564. 15 indexed citations
14.
Cattaneo, Marco, Maurizio Vecchi, Maddalena L. Zighetti, et al.. (1998). High prevalence of hyperchomocysteinemia in patients with inflammatory bowel disease: a pathogenic link with thromboembolic complications?. PubMed. 80(4). 542–5. 83 indexed citations
15.
Franchis, Roberto de, Paolo Omodei, T Ranzi, et al.. (1997). Controlled trial of oral 5‐aminosalicylic acid for the prevention of early relapse in Crohn's disease. Alimentary Pharmacology & Therapeutics. 11(5). 845–852. 42 indexed citations
16.
Vecchi, Maurizio, Mauro Bianchi, Renato Alberto Sinico, et al.. (1994). Antibodies to Neutrophil Cytoplasm in Italian Patients with Ulcerative Colitis: Sensitivity, Specificity and Recognition of Putative Antigens. Digestion. 55(1). 34–39. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026